-
2022-501417-31-00
5
High-risk Resected Melanoma
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-500631-36-00
5
Focal cerebral arteriopathy and childhood stroke
Focal cerebral arteri
-
2023-504592-24-00
4
sexual/ erectile function in women and men after treatment for rectal
-
2023-504654-35-00
4
Graves Ofthalmopathy
-
2023-504846-73-01
4
Glioblstoma WHO grade IV
-
2023-509392-17-00
5
Relapsed Acute Lymphoblastic Leukemia (ALL)
-
2023-509534-18-01
4
Myelom
-
2024-512195-35-00
5
Stage I adenocarcinoma non-small cell lung cancer (NSCLC) with ctDNA-p
-
2024-512721-89-00
4
Breast Cancer
-
2024-513724-42-00
10
Medulloblastoma
-
2024-513778-23-00
5
Colon and rectal cancer tumor stage II-III, tumor with somatic alterat
-
2024-514818-12-00
6
Breast cancer female NOS
-
2024-515250-25-00
3
Advanced KRASG12C-mutated non-small cell lung cancer subjects who prev
-
2024-516003-16-00
4
Advanced Cancer
-
2024-516723-14-00
6
Rheumatoid Arthritis
-
2024-517052-35-00
6
Transsexual
-
2024-517315-69-00
5
Vulvovaginal atrophy symptoms
-
2024-517546-33-00
1
Geographic atrophy secondary to dry age-related macular degeneration
-
2024-517594-24-01
9
Cervical carcinoma
-
2024-517649-15-00
6
Allergic rhinitis due to dog allergy
-
2024-518013-25-00
4
Idiopathic Pulmonary Fibrosis
-
2024-518016-39-00
10
Respiratory tract diseases
-
2024-518977-32-00
5
Breast Cancer, Acute Leukemia, Lymphomas (Hodgkin and non-Hodgkin) ans